Presentation is loading. Please wait.

Presentation is loading. Please wait.

Presented by Sam Annor Elma Stapic. Definition (by Elma) Background (by Sam) Advantages (by Elma) Disadvantages (by Sam) Conclusion.

Similar presentations


Presentation on theme: "Presented by Sam Annor Elma Stapic. Definition (by Elma) Background (by Sam) Advantages (by Elma) Disadvantages (by Sam) Conclusion."— Presentation transcript:

1 Presented by Sam Annor Elma Stapic

2 Definition (by Elma) Background (by Sam) Advantages (by Elma) Disadvantages (by Sam) Conclusion

3

4 Gene patenting is a broad term referring to the patenting of either a process that involves isolation of DNA as well as to a chemical substance related to DNA

5 There has been a flood of patent requests for genes and small pieces of gene sequences known as expressed sequence tags (ESTs) as the completion of human genome mapping. The expected total number of working human genes is said to be somewhere between 28,000 and 100,000

6 Only 4% of the total human genome Has their function known. On the other hand, the function of the remainder 96% of the genetic information is unknown. Hence, owning any sequence of them now may be beneficial to a patent holder later, when its function become known

7 Gives patent holders great deal of power. To preserve ingenuity. To give credit to who credit is due. Ensures development and progress in gene technology. regain the cost and labor invested into research

8 Highly unethical because humans are special possess sanctity. hinders innovation. Restrictions imposed by the patent holders have resulted in unaffordability, inaccessibility, less development of gene therapy and inconvenience.

9 Food for thought….. Do you think any part of our genes should be patented?

10


Download ppt "Presented by Sam Annor Elma Stapic. Definition (by Elma) Background (by Sam) Advantages (by Elma) Disadvantages (by Sam) Conclusion."

Similar presentations


Ads by Google